通过p53-p21通路抑制诱导的多能干细胞生成
Hyenjong Hong1, Kazutoshi Takahashi, Tomoko Ichisaka
1Center for iPS Cell Research and Application (CiRA), Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8507, Japan.
Nature
|August 12, 2009
概括
抑制p53 (瘤抑制剂) 显著增强来自各种细胞类型的诱导多能干细胞 (iPS) 产生. 这一发现揭示了p53的存在.
科学领域:
- 干细胞生物学 干细胞生物学
- 癌症生物学 癌症生物学
- 分子遗传学 分子遗传学
背景情况:
- 从体细胞诱导的多能干细胞 (iPS) 产生通常需要特定的转录因子 (Oct3/4,Sox2,Klf4,c-Myc).
- 将体细胞重新编程成iPS细胞的效率仍然是一个重大挑战.
- 对于p53在调节iPS细胞生成效率中的作用尚不完全理解.
研究的目的:
- 研究p53抑制对iPS细胞生成效率的影响.
- 阐明p53影响重编程的基本机制.
- 为了确定参与多能诱导过程的p53调节基因.
主要方法:
- 产生p53缺乏的小鼠胚胎纤维细胞.
- 使用具有或没有p53抑制的定义因子对小鼠和人类体细胞进行重新编程.
- 对iPS电池生成效率和特征的分析.
- 用DNA微阵列分析识别p53调节基因.
- 已识别的基因的功能分析.
主要成果:
- 删除p53 (瘤抑制剂) 在小鼠纤维细胞中显著提高了iPS细胞生成效率,在没有c-Myc.的情况下达到10%.
- 缺少p53促进了通过等离子体转染生成无集成iPS细胞,并使终端分化T淋巴细胞的重编程成为可能.
- 抑制p53也提高了人类iPS细胞生成效率.
- DNA微阵列在小鼠和人类纤维细胞中发现了34个常见的p53-调节基因,涉及到p53-p21通路.
结论:
- p53-p21通路作为有效的iPS细胞生成的关键障碍,除了它在预防瘤发生方面的已知作用外.
- 针对p53通路提供了一个有前途的策略,以提高iPS细胞技术的效率和适用性.
- 了解p53的作用,可以了解干细胞重编程和癌症生物学.
更多相关视频
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
6.7K
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.6K
相关概念视频
Induced Pluripotent Stem Cells
28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells
4.1K
No description available
4.1K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Induced Pluripotent Stem Cells
6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.3K
Somatic to iPS Cell Reprogramming
2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
